Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.

@article{Weng2008MinimallyIT,
  title={Minimally invasive treatment combined with cytokine-induced killer cells therapy lower the short-term recurrence rates of hepatocellular carcinomas.},
  author={De-sheng Weng and Jun Gang Zhou and Qingfeng Zhou and Mingming Zhao and Qi-jing Wang and Li-xi Huang and Yong-Qiang Li and Shi-Ping Chen and Peihong Wu and Jian-Chuan Xia},
  journal={Journal of immunotherapy},
  year={2008},
  volume={31 1},
  pages={63-71}
}
The recurrence of hepatocellular carcinoma (HCC) after minimally invasive therapy is frequent. Adoptive immunotherapy is thought to be an effective method to lower recurrence and metastasis rates of malignant tumors. Therefore, 85 HCC patients after transcatheter arterial chemoembolization and radiofrequency ablation therapy were randomized to immunotherapy group and no adjuvant therapy group. Autologous cytokine-induced killer (CIK) cells were transfused via hepatic artery to the patients. The… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 57 extracted citations

Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma.

Journal of clinical & cellular immunology • 2015
View 5 Excerpts
Highly Influenced

Postoperative therapy options for hepatocellular carcinoma.

Scandinavian journal of gastroenterology • 2014
View 7 Excerpts
Highly Influenced

Specific immunotherapy in hepatocellular cancer: A systematic review.

Journal of gastroenterology and hepatology • 2017
View 4 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…